Dear Reader, The next few months could be the biggest moneymaking opportunity of any of our lives. In short: The Melt Up is back on – right now. Stocks are at all time highs... with big tech leading the way. It's exactly what we expect to see. And we're nowhere near the top yet. But even though stocks like Apple... Tesla... and Nvidia are getting the most attention – there's a sector that's historically done even better in these exact same conditions... And by a massive margin: Biotech. Just look at what happened in early 2000... Now it's happening all over again. Which is why I've recommended biotech stocks to my True Wealth Systems readers. But, there's no denying... the biggest gains by far will be in individual biotech stocks. That's not my specialty. But that's where my colleague Dave Lashmet thrives. Just in the past few months, Dave has landed a 777% win... along with a record-breaking 1,139% return on a vaccine-maker. Now, he's just shared the details of one of the most exciting opportunities of his 20-plus year career. A tiny firm whose drug could end a global health crisis. Dave says this ONE single stock could return a whopping 2,000%... and be the biggest stock win in Stansberry Research history. And I certainly wouldn't bet against him. He lays out the details right here. By the way, if you take a look at Dave's presentation, he actually gives away another one of his closely guarded Stansberry Venture Technology stock ideas. (*Hint: Look for the name of the competing drug... the ticker symbol is a Google search away from there). It's a stock you can go buy right away, if you choose, without spending a penny to receive. Take a look. I highly recommend you have some exposure to the upside in biotech stocks today. And if you want the details on the grossly undervalued pick Dave has uncovered (again – a tiny drug company with 2,000% upside) – then take a look Dave's presentation right away. It will only be online for a few days. Good investing, Steve Sjuggerud | 